162 related articles for article (PubMed ID: 33610487)
21. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Eur Urol Focus; 2023 Jan; 9(1):125-132. PubMed ID: 35918270
[TBL] [Abstract][Full Text] [Related]
22. Personalized Treatment for Small Renal Tumors: Decision Analysis of Competing Causes of Mortality.
Kang SK; Huang WC; Elkin EB; Pandharipande PV; Braithwaite RS
Radiology; 2019 Mar; 290(3):732-743. PubMed ID: 30644815
[TBL] [Abstract][Full Text] [Related]
23. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
24. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
25. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
26. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
27. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
[TBL] [Abstract][Full Text] [Related]
28. Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients.
Jang HA; Kim JW; Byun SS; Hong SH; Kim YJ; Park YH; Yang KS; Cho S; Cheon J; Kang SH
Cancer Res Treat; 2016 Apr; 48(2):612-20. PubMed ID: 26044158
[TBL] [Abstract][Full Text] [Related]
29. Treatment management of small renal masses in the 21st century: a paradigm shift.
Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
[TBL] [Abstract][Full Text] [Related]
30. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
31. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
[TBL] [Abstract][Full Text] [Related]
32. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
[TBL] [Abstract][Full Text] [Related]
33. Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.
Roos FC; Steffens S; Junker K; Janssen M; Becker F; Wegener G; Brenner W; Steinestel J; Schnoeller TJ; Schrader M; Hofmann R; Thüroff JW; Kuczyk MA; Wunderlich H; Siemer S; Hartmann A; Stöckle M; Schrader AJ;
BMC Cancer; 2014 May; 14():372. PubMed ID: 24885955
[TBL] [Abstract][Full Text] [Related]
34. Comparison among cryoablation, radiofrequency ablation, and partial nephrectomy for renal cell carcinomas sized smaller than 2 cm or sized 2-4 cm: A population-based study.
Yan S; Yang W; Zhu CM; Yan PM; Wang ZC
Medicine (Baltimore); 2019 May; 98(21):e15610. PubMed ID: 31124938
[TBL] [Abstract][Full Text] [Related]
35. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
36. Overall survival advantage with partial nephrectomy: a bias of observational data?
Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
[TBL] [Abstract][Full Text] [Related]
37. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
38. Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study.
Takagi T; Kondo T; Iizuka J; Omae K; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
BJU Int; 2016 Jun; 117(6B):E52-9. PubMed ID: 26073989
[TBL] [Abstract][Full Text] [Related]
39. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
Zini L; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Antebi E; Saad F; Patard JJ; Montorsi F; Karakiewicz PI
Cancer; 2009 Apr; 115(7):1465-71. PubMed ID: 19195042
[TBL] [Abstract][Full Text] [Related]
40. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.
Sun M; Becker A; Tian Z; Roghmann F; Abdollah F; Larouche A; Karakiewicz PI; Trinh QD
Eur Urol; 2014 Jan; 65(1):235-41. PubMed ID: 23567066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
